Related Experiment Video
Updated: Apr 26, 2026

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
Published on: December 9, 2022
Lycopodine-Type Alkaloids from Lycopodium japonicum
Juan He1, Xing-De Wu1, Fei Liu1
1State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201 China.
Researchers isolated novel lycopodine-type alkaloids from Lycopodium japonicum, including compounds 1-4. These alkaloids were then evaluated for their potential acetylcholine esterase inhibitory activity.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacognosy
Background:
- The club moss Lycopodium japonicum is a rich source of bioactive alkaloids.
- Lycopodium alkaloids, particularly the lycopodine-type, have shown diverse pharmacological activities.
Purpose of the Study:
- To isolate and characterize new alkaloids from Lycopodium japonicum.
- To evaluate the acetylcholine esterase inhibitory activity of the isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation via extensive spectroscopic methods (NMR, MS) and X-ray crystallography.
- In vitro evaluation of acetylcholine esterase inhibitory activity.
Main Results:
- Three new lycopodine-type alkaloids (1-3) and an artifact (4) were identified.
- Seventeen known related alkaloids were also isolated.
- Compounds 1-4 demonstrated varying degrees of acetylcholine esterase inhibition.
Conclusions:
- The study expands the known chemical diversity of Lycopodium alkaloids.
- The isolated compounds, particularly 1-4, show potential as acetylcholine esterase inhibitors, warranting further investigation.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Drugs that Stabilize Microtubules
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs Acting on Autonomic Ganglia: Blockers
Drugs that Destabilize Microtubules
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

